Evidence of corneal lymphangiogenesis in dry eye disease: A potential link to adaptive immunity?

Archives of Ophthalmology

Volumn 128, Issue 7, 2010, Pages 819-824

  Goyal, Sunali ^a,b   Chauhan, Sunil K ^a,b   El Annan, Jaafar ^a,b   Nallasamy, Nambi ^b   Zhang, Qiang ^a,b   Dana, Reza ^a,b,c  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RNA; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CELL HOMING; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORNEA DISEASE; CORNEAL LYMPHANGIOGENESIS; DESICCATION; DRY EYE; FEMALE; FLOW CYTOMETRY; INFLAMMATION; LYMPH NODE; LYMPH VESSEL; LYMPHANGIOGENESIS; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, CD31; CELL COUNT; CORNEAL DISEASES; DISEASE MODELS, ANIMAL; DRY EYE SYNDROMES; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLYCOPROTEINS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 77955004273     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2010.124     Document Type: Article

References (26)

1. Research in dry eye: report of the Research Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;5(2):179-193.
2. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol. 2003;136(2):318-326.
3. Chauhan SK, Dana R. Role of Th17 cells in the immunopathogenesis of dry eye disease. Mucosal Immunol. 2009;2(4):375-376.
4. Niederkorn JY, Stern ME, Pflugfelder SC, et al. Desiccating stress induces T cell-mediated Sjögren's syndrome - like lacrimal keratoconjunctivitis. J Immunol. 2006;176(7):3950-3957.
5. Stern ME, Gao J, Schwalb TA, et al. Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye. Invest Ophthalmol Vis Sci. 2002;43(8):2609-2614.
6. El Annan J, Chauhan SK, Ecoiffier T, Zhang Q, Saban DR, Dana R. Characterization of effector T cells in dry eye disease. Invest Ophthalmol Vis Sci. 2009;50(8):3802-3807.
7. Chauhan SK, El Annan J, Ecoiffier T, et al. Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J Immunol. 2009;182(3):1247-1252.
8. Yamagami S, Dana MR. The critical role of lymph nodes in corneal alloimmunization and graft rejection. Invest Ophthalmol Vis Sci. 2001;42(6):1293-1298. (Pubitemid 32381972)
9. Cursiefen C. Immune privilege and angiogenic privilege of the cornea. Chem Immunol Allergy. 2007;92:50-57. doi:10.1159/000099253.
10. Barabino S, Shen L, Chen L, Rashid S, Rolando M, Dana MR. The controlled-environment chamber: a new mouse model of dry eye. Invest Ophthalmol Vis Sci. 2005;46(8):2766-2771.
11. Rashid S, Jin Y, Ecoiffier T, Barabino S, Schaumberg DA, Dana MR. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch Ophthalmol. 2008;126(2):219-225.
12. 1 (VLA-4) in dry eye disease. Arch Ophthalmol. 2008;126(12):1695-1699.
13. Heloterä H, Alitalo K. The VEGF family: the inside story. Cell. 2007;130(4):591-592.
14. Mäkinen T, Alitalo K. Lymphangiogenesis in development and disease. Novartis Found Symp. 2007;283:87-98, discussion 98-105, 238-241.
15. Maruyama K, Ii M, Cursiefen C, et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest. 2005;115(9):2363-2372.
16. Hamrah P, Zhang Q, Dana MR. Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in the conjunctiva: a potential link between lymphangiogenesis and leukocyte trafficking on the ocular surface. Adv Exp Med Biol. 2002;506(pt B):851-860. (Pubitemid 36308272)
17. Ji RC. Lymphatic endothelial cells, inflammatory lymphangiogenesis, and prospective players. Curr Med Chem. 2007;14(22):2359-2368.
18. Ambati BK, Nozaki M, Singh N, et al. Corneal avascularity is due to soluble VEGF receptor-1. Nature. 2006;443(7114):993-997.
19. Cursiefen C, Cao J, Chen L, et al. Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci. 2004;45(8):2666-2673.
20. Paavonen K, Puolakkainen P, Jussila L, Jahkola T, Alitalo K. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol. 2000;156(5):1499-1504. (Pubitemid 30646689)
21. Cursiefen C, Chen L, Borges LP, et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest. 2004;113(7):1040-1050.
22. Ny A, Koch M, Vandevelde W, et al. Role of VEGF-D and VEGFR-3 in developmental lymphangiogenesis, a chemicogenetic study in Xenopus tadpoles. Blood. 2008;112(5):1740-1749.
23. Kerjaschki D. The crucial role of macrophages in lymphangiogenesis. J Clin Invest. 2005;115(9):2316-2319.
24. Xu H, Chen M, Reid DM, Forrester JV. LYVE-1-positive macrophages are present in normal murine eyes. Invest Ophthalmol Vis Sci. 2007;48(5):2162-2171. (Pubitemid 351261290)
25. Jackson DG. Immunological functions of hyaluronan and its receptors in the lymphatics. Immunol Rev. 2009;230(1):216-231.
26. Chen L, Hamrah P, Cursiefen C, et al. Vascular endothelial growth factor receptor-3 mediates induction of cornea alloimmunity. Nat Med. 2004;10(8):813-815.